Search Results
Nov 12, 2025, 07:30 ET Alkermes Announces Positive Topline Results From Vibrance-2 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 2
1 Ruoff C, Rye D. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality. Curr Med Res Opin. 2016;32(10):1611-1622. doi:10.1080/03007995.2016.12086432 Bassetti CLA, Adamantidis A, Burdakov D, et al. Narcolepsy –
More news about: Alkermes plc
Nov 12, 2025, 07:02 ET Møt Raccoon 2 SE på Kickstarter - For å bringe AI-drevet plenklipping til små hager
Glem besværet med grenseledninger eller kompliserte RTK-installasjoner. Med Raccoon 2 SE kan brukere komme i gang med plenklippen rett fra boksen.
More news about: RoboUp
Nov 11, 2025, 13:21 ET True Global Ventures två stora milstolpar i portföljen inom 72 timmar i USA
Rodrigues, VD för Forge Global, tillade: "Detta partnerskap med Charles Schwab representerar en vändpunkt för de privata marknaderna. Forge byggdes för att demokratisera tillgången till investeringar i privata företag, och att gå samman med en av världens mest betrodda finansiella institutioner kommer
More news about: True Global Ventures
Nov 11, 2025, 02:29 ET RefluxStop® takes center stage at 2025 European Foregut Society meeting
long-term and real-world outcomes data. The distinguished panel of RefluxStop experts included: Prof. Sebastian Schoppmann, Dr. med. Yves Borbély, Dr. med. Moustafa Elshafei and Dr. med. Thorsten Lehmann. They provided an in-depth perspective on RefluxStop® to treat reflux disease, followed by constructive
More news about: Implantica
Nov 10, 2025, 14:46 ET NYC Marathoner and Med Student Qualifies for U.S. Olympic Trials with Support from Dry Needling and Acupuncture
multimedia:https://www.prnewswire.com/news-releases/nyc-marathoner-and-med-student-qualifies-for-us-olympic-trials-with-support-from-dry-needling-and-acupuncture-302610584.html
More news about: Morningside Acupuncture PLLC
Nov 10, 2025, 09:08 ET The Inception Company and Data360 Announce Strategic Partnership to Transform HCP Engagement Through Dynamic Digital Events
Scalable Programs: Extend reach and engagement across live, virtual, and hybrid formats for brands, med affairs, and clinical education teams. This partnership enables brands and agencies to move beyond basic
More news about: The Inception Company
Nov 10, 2025, 09:00 ET Rapid zalunfiban treatment at 1st point of medical contact lowered risk of more severe heart damage in combination with other serious heart-attack complications
Continuous quality improvement for prehospital STEMI improved triage rates and achievement of gold standard < 90-min EMS-to-balloon time. Int J Emerg Med. 2025 Mar 12;18(1):53. doi: 10.1186/s12245-025-00863-x. PMID: 40075278; PMCID: PMC11905686.
More news about: CeleCor Therapeutics, Inc.
Nov 10, 2025, 08:46 ET Novo Nordisk's Wegovy® (semaglutide 2.4 mg) was associated with liver health-related benefits not solely based on weight loss in adult patients with MASH with liver scarring, according to a new post hoc analysis
Sanyal AJ, Newsome PN, Kliers I, et al. Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis. New Eng J Med. 2025;392(21): 2089-2099.
More news about: NOVO NORDISK INC.
Nov 10, 2025, 08:45 ET Novo Nordisk's Wegovy® (semaglutide 2.4 mg) was associated with liver health-related benefits not solely based on weight loss in adult patients with MASH with liver scarring, according to a new post hoc analysis
Sanyal AJ, Newsome PN, Kliers I, et al. Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis. New Eng J Med. 2025;392(21): 2089-2099.
More news about: NOVO NORDISK INC.
Nov 10, 2025, 08:32 ET Rajani MD Debuts the New PlasmaGLO™ HALO LED Face, Neck, & Hair Mask -- The Next Generation of At-Home Beauty Tech
jowls, crow's feet, vertical lip lines, and under-eye hollows. In just 10 minutes of daily use, users can experience clinic-grade results—no downtime or med spa visit required. "The new PlasmaGLO HALO Mask represents the evolution of intelligent at-home beauty rejuvenation," said Dr.
More news about: Rajani MD
Nov 10, 2025, 08:00 ET Vexev's VxWave System Successfully Meets Clinical Endpoints in Landmark Study Evaluating Robotic Ultrasound Scanning for Mapping Vascular Access at U.S. Renal Care Dialysis Clinics
imaging approach can enhance care across our network." About VexevVexev is an Australian med‑tech startup founded in 2018 by Dr. John Carroll and Dr. Eamonn Colley, experts in vascular fluid dynamics and computational imaging, dedicated to transforming
More news about: Vexev
Nov 10, 2025, 08:00 ET Johnson & Johnson lança plataforma VARIPULSE™ no Brasil e avança no tratamento da fibrilação atrial
iii Anter, E., Mansour, M., Nair, D.G. et al. Dual-energy lattice-tip ablation system for persistent atrial fibrillation: a randomized trial. Nat Med 30, 2303–2310 (2024). https://doi.org/10.1038/s41591-024-03022-6 pg 2 iv Reddy
More news about: Johnson & Johnson MedTech
Nov 09, 2025, 20:53 ET Sunseeker Robotics LiDAR Mower S4 utsedd till CES Innovation Awards® 2026 Honoree
gräsklipparen på tre år som tilldelas denna prestigefyllda utmärkelse. Programmet CES Innovation Awards® 2026 mottog ett rekordstort antal bidrag med över 3600. Tillkännagivandet kommer inför CES® 2026, världens ledande teknikmässa, som äger rum 6-9 januari i Las Vegas, Nevada.
More news about: Sunseeker Robotics
Nov 09, 2025, 20:51 ET Sunseeker Robotics LiDAR Mower S4 udnævnt til CES Innovation Awards® 2026 Honoree
under forskellige forhold. Sunseeker S4 er bygget til at navigere i komplekse haver med lethed og kombinerer intelligent navigation, stærk tilpasningsevne og en strømlinet opsætningsproces for at levere præcis græspleje med lav vedligeholdelse. "Vi er beærede over, at Sunseekers trådløse
More news about: Sunseeker Robotics
Nov 09, 2025, 20:48 ET Sunseeker Robotics LiDAR Mower S4 utnevnt som æresgjest under CES Innovation Awards® 2026
varierende forhold. Sunseeker S4 er bygget for å enkelt navigere i komplekse hager med en kombinasjon av intelligent navigering, sterk tilpasningsevne og en strømlinjeformet oppsettprosess for å levere presis plenpleie med minimalt vedlikehold. «Vi er begeistret over at Sunseekers
More news about: Sunseeker Robotics
Nov 08, 2025, 08:30 ET AusperBio Announces Late-Breaking 48-Week Phase II Data of AHB-137 in Chronic Hepatitis B at AASLD 2025
developed a proprietary Med-OligoTM ASO platform which has been shown to substantially enhance the current ASO therapeutics, through novel insights into ASO design. Combining efficient targeted delivery conjugation technologies, the modular Med-OligoTM Platform empowers ASO
More news about: AusperBio Therapeutics Inc.
Nov 07, 2025, 10:08 ET Dahua Technology afslører regionalt knudepunkt i Budapest, der strategisk styrker det globale AIoT-økosystem og lokal værdiskabelse
lokaliserede aktiviteter. Med fokus på stærkere lokal service og support ønsker Dahua at opbygge kundernes tillid, udvide sin markedsdækning og sikre vedvarende vækst. Showroomet fungerer som en multifunktionel platform, der tilbyder produktdemonstrationer, tekniske løsninger og uddannelse, med det formål at styrke
More news about: Dahua Technology
Nov 07, 2025, 09:31 ET Dahua Technology inviger regionalt nav i Budapest och stärker det globala AIoT-ekosystemet och den lokala värdeskapandet
40 länder och regioner, mer än 600 anställda, ett nätverk av över 10 000 kunder och partners samt ett dedikerat servicenätverk med över 20 lokala center och 18 supportlinjer med 24-timmars tillgänglighet. "Under de senaste åren har Dahua lanserat mer avancerade, innovativa och marknadsledande
More news about: Dahua Technology
Nov 07, 2025, 09:29 ET Dahua Technology avduker regionalt knutepunkt i Budapest for strategisk oppheving av et globalt AIoT-økosystem og lokalisert verdiskaping
Med slagordet «Sammen bygger vi en fremtid» viste arrangementet Dahuas smarte IoT og intelligente løsninger, og samlet regionale distributører, systemintegratorer
More news about: Dahua Technology
Nov 07, 2025, 09:00 ET CREATE Medicines Announces Positive First-in-Human Results for MT-302
data provide important mechanistic insights into how in vivo programmed myeloid cells behave within the tumor microenvironment," said Rasha Cosman BSc (Med), MBBS, FRACP, Head of the Early Phase Clinical Trials Unit at The Kinghorn Cancer Centre, St. Vincents Hospital Sydney, "The degree of remodeling observed,
More news about: CREATE Medicines, Inc.
Nov 07, 2025, 08:49 ET 46% Drop in Mental Energy? The FoundationMED Report That Has Every Industry on Edge
offices, no sector is immune. The findings suggest a universal pattern of energy collapse impacting focus, creativity, and emotional regulation. Foundation Med emphasizes that organizations can no longer treat brain health as an individual concern but as a core metric of performance and sustainability.
More news about: FoundationMED
Nov 07, 2025, 08:30 ET FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma
doi:10.1038/s41467-021-22140-03 Maura, F, Bergsagel PL. Targeting the Tumor and the Immune System in Smoldering Multiple Myeloma. N Engl J Med. 2025;392:1858-1860. doi: 10.1056/NEJMe25042734 American Cancer Society. Myeloma Cancer Statistics. Accessed June 2025. Available
More news about: Halozyme Therapeutics, Inc.
Nov 07, 2025, 08:11 ET Outcomes Rocket and Censinet Announce Exclusive AI-Focused Healthcare Series from AI Med 2025
collaborative series recorded at AI Med 2025. SAN DIEGO, Nov. 7, 2025 /PRNewswire/ -- Outcomes Rocket and Censinet today announced the AI Med 2025 Insights Series, a
More news about: Outcomes Rocket
Nov 07, 2025, 07:30 ET Laborie Announces Agreement to Acquire the JADA® System from Organon
standard of care in postpartum hemorrhage (PPH) management" said Organon interim Chief Executive Officer (CEO) Joseph Morrissey. "This transaction puts a med tech asset in the hands of Laborie, a leading medical technology innovator with an established history in maternal health well-positioned to further
More news about: Laborie Medical Technologies
Nov 06, 2025, 17:07 ET DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma
doi:10.1038/s41467-021-22140-04 Maura, F, Bergsagel PL. Targeting the Tumor and the Immune System in Smoldering Multiple Myeloma. N Engl J Med. 2025;392:1858-1860. doi: 10.1056/NEJMe25042735 American Cancer Society. Myeloma Cancer Statistics. Accessed November 2025. Available
More news about: Johnson & Johnson